~~<i id='E226E0D96E'><strike id='E226E0D96E'><tt id='E226E0D96E'><pre id='E226E0D96E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：knowledge 2025-08-23 08:55:01 - browse：7

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Bristol 'take

entertainment

explore

hotspot

focus

entertainment

focus

A"welcomehome"blessingmadeofstonesitsatNissimKahlon'shomechiseledoutofthesandstonecliffsoverlookingt

WSS

Companies helping big Covid

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

After half a century, Israel moves to evict squatter from his cave home on the beach

FDA authorizes Novavax’s updated Covid

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Vermont grapples with historic flooding as more rainstorms head for Northeast

focus

leisure time

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

A Q&A with the global head of Boehringer Ingelheim's innovation unit

United colonoscopy coverage change 'may cost lives,' doctors say

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

The cancer drug shortage isn’t new — and neither are the solutions

EU fines Illumina $475 million over Grail acquisition

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Walensky prepares to leave CDC — and Congress — behind

A virus, fished out of a lake, may have saved a man’s life

explore

The debate over Covid

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Bill would stop addiction treatment from triggering child abuse inquiry

Liquid biopsy for lung cancer is launched by Delfi

Sana to lay off nearly a third of staff, de

Chan Zuckerberg Biohub Chicago to focus on inflammation

hotspot

focus

entertainment

focus